Gang Wu

11PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 08, 2026
Disitamab vedotin in combination with lenvatinib for patients with HER2-positive unresectable locally advanced or metastatic biliary tract cancer: study protocol of a phase II clinical trial.

Yongqiang Yang, Jinfeng Zhang, Zilong Wu

|Dec 18, 2025
Stereotactic body radiotherapy with sintilimab and bevacizumab biosimilar in anti-PD-1 refractory hepatocellular carcinoma: the ReUNION-1 phase 2 trial.

Jing Tang, Yongqiang Yang, Dongen Liu

|Mar 18, 2025
Retraction Note: β-Trcp and CK1δ-mediated degradation of LZTS2 activates PI3K/AKT signaling to drive tumorigenesis and metastasis in hepatocellular carcinoma.

Yanwei Lu, Xudong Li, Hongli Liu

|Jan 31, 2024
Targeting FBXO22 enhances radiosensitivity in non-small cell lung cancer by inhibiting the FOXM1/Rad51 axis.

Yunshang Chen, Yun Zhou, Xue Feng

|Feb 27, 2023
CEMIP, acting as a scaffold protein for bridging GRAF1 and MIB1, promotes colorectal cancer metastasis via activating CDC42/MAPK pathway.

Guojie Xu, Lei Zhao, Qingling Hua

|Oct 21, 2022
NLRP6 is required for cancer-derived exosome-modified macrophage M2 polarization and promotes metastasis in small cell lung cancer.

Xinrui Rao, Xiaoshu Zhou, Geng Wang

Pageof 2

Frequent Collaborators

4 joint publications

Shuangbing Xu

4 joint publications

Yingzhuo Xu

3 joint publications

Zhenyu Li

3 joint publications

Tao Zhang